Skip to main content

Cover Story

First Report Managed Care
As candidates continue to debate health care, our experts took a look beyond the rhetoric and main talking points of five of the leading democratic contenders to analyze what they are—and potentially are not—telling payers, providers, and patients.
First Report Managed Care
Jake Frenz, CEO and founder of SmithRx, outlines his health care vision through the prism of his growing start-up, breaking down what is wrong with the traditional way of managing the pharmacy benefit, and explains how he and his company are shaking things up.
First Report Managed Care
The IRS, with input from HHS, expands list of preventive care options for HSA participants with high deductible health plans; our experts offer insights, predict the level of adoption, and address potential downsides.
First Report Managed Care
Pharmaceutical developments are not keeping pace with mutations in antibiotics; and, while international stakeholders recognize the severity of antimicrobial resistance, new breakthroughs in technology are needed to combat this threat.
First Report Managed Care
Many are clamoring for Medicare for All, so the Democratic presidential candidates have jumped on the bandwagon—or so it seems. Our panelists look beyond the headlines and analyze what is really being said, and what changes will come if a Democrat prevails in 2020.
First Report Managed Care
The Senate Finance Committee recently examined the complicated role pharmacy benefit managers play in the pricing of pharmaceuticals. Six prominent themes emerged. First Report Managed Care consulted with a panel of experts to assess the impact.
First Report Managed Care
Donald Rucker, MD, discusses progress in the areas of interoperability, reducing provider burden, and giving patients more control of their health data, as well as suggests how managed care stakeholders can position themselves for success as the health care app economy expands.
First Report Managed Care
In early 2018, the US Department of Labor proposed a rule that would alter the regulation of association health plans. Now, one year after our original February 2018 analysis of the deregulation, we turn to our panel of experts to gain insight on the emerging trends, whether initial concerns came…
First Report Managed Care
In the summer of 2018, First Report Managed Care reported on the Trump Administration’s drug price blueprint and checked back in during the fall to track progress. Now in the new year, First Report Managed Care’s panel of experts parsed through the latest efforts to control drug spending and…
First Report Managed Care
Drug shortages have been more prevalent in recent years. Now, the US Food and Drug Administration (FDA), pharmaceutical companies, and other stakeholders are beginning to work together to open conversations about the issue’s causes and potential solutions to address them.
Back to Top